This article is more than 5 years old. Information may no longer be current.

NFID, ICID offering free CME program on influenza vaccine

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

A free online CME program focuses on the challenges of improving influenza vaccine uptake in Americans aged 65 years and older.

The “Influenza Knowledge Transfer Series” was developed by the National Foundation for Infectious Diseases (NFID) and the International Centre for Infectious Diseases.

William Schaffner

“It’s a very comprehensive introduction to influenza and influenza immunization focused particularly on people age 65 and older,” William Schaffner, MD, Infectious Disease News Editorial Board member, NFID medical director and professor of preventive medicine at Vanderbilt University School of Medicine, said in an interview.

In September, the CDC reported what it called a concerning decline in influenza vaccinations among older Americans, including a 3.3 percentage point dip in those aged 65 years and older. The new CME is aimed at getting those numbers up.

“I would say just about any question you had about influenza and the influenza vaccine is addressed in this very comprehensive CME program,” Schaffner said. – by Gerard Gallagher

For more information:

NFID, ICID. Influenza knowledge transfer series. 2016. http://resources.us.mdpassport.com/en/kts-flu/. Accessed Nov. 17, 2016.

Disclosures: Schaffner reports being a member of the data safety monitoring boards for Merck and Pfizer, a consultant for Dynavax, Novavax, GlaxoSmithKline and Sanofi Pasteur, and a lecturer for Genentech.